Not yet recruiting
A Study to Assess Efficacy and Safety of Adimanebart in Adult and Pediatric Participants With DOK7-,MUSK-, AGRN-, or LRP4- Congenital Myasthenic Syndromes (CMS)
NCT07746089
- Conditions
- CMS, Congenital Myasthenic Syndrome, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +5 more
- Locations
-
Not specified